Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms

World Journal of Gastroenterology

Volumn 16, Issue 42, 2010, Pages 5353-5358

  Lee, Jin Hee ^a   Lee, Kyu Taek ^a   Park, Jongwook ^a   Bae, Sun Youn ^a   Lee, Kwang Hyuck ^a   Lee, Jong Kyun ^a   Jang, Kee Taek ^a   Heo, Jin Seok ^a   Choi, Seong Ho ^a   Choi, Dong Wook ^a   Rhee, Jong Chul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Intraductal papillary mucinous neoplasms; Malignancy; Pancreatic neoplasms; Predictive factors

Indexed keywords

MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC;

ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCINOUS CARCINOMA; PANCREAS CARCINOMA; PAPILLOMA; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; REVIEW; TUMOR VOLUME;

EID: 78649435197     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i42.5353     Document Type: Review

References (23)

1. Klöppel G, Solcia E, Longneker DS, Capella C, Sobin LH. Histological typing of tumours of the exocrine pancreas. In: World Health Organization International Classification of Tumors, 2nd ed. Berlin: Springer, 1996: 11-20
2. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, Han JK, Kim WH, Lee YJ, Kim SC, Han DJ, Kim YI, Choi SH, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee KB, Kim YC, Lee KS, Kim MW, Kim HJ, Kim HJ, Park YH. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005; 12: 124-132
3. Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Predictive factors of malignant or invasive intraductal papillary- mucinous neoplasms of the pancreas. J Gastrointest Surg 2007; 11: 338-344
4. Nagai K, Doi R, Kida A, Kami K, Kawaguchi Y, Ito T, Sakurai T, Uemoto S. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and longterm follow-up after resection. World J Surg 2008; 32: 271-278; discussion 279-280
5. Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 2009; 38: 8-16
6. Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg 2010; 34: 776-783
7. Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillarymucinous tumours of the pancreas. Br J Surg 2003; 90: 1244-1249
8. Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 2003; 138: 610-617; discussion 617-618
9. Ito H, Endo T, Oka T, Matumoto T, Abe T, Toyota M, Imai K, Satoh M, Maguchi H, Shinohara T. Mucin expression profile is related to biological and clinical characteristics of intraductal papillary-mucinous tumors of the pancreas. Pancreas 2005; 30: e96-e102
10. Kanno A, Satoh K, Kimura K, Hirota M, Umino J, Masamune A, Satoh A, Asakura T, Egawa S, Sunamura M, Endoh M, Shimosegawa T. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2006; 33: 391-396
11. Lee SY, Choi DW, Jang KT, Lee KT, Choi SH, Heo JS, Lee JK, Paik SW, Rhee JC. High expression of intestinal-type mucin (MUC2) in intraductal papillary mucinous neoplasms coexisting with extrapancreatic gastrointestinal cancers. Pancreas 2006; 32: 186-189
12. Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol 2002; 197: 632-637
13. Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology 2005; 52: 398-403
14. Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg 2007; 14: 243-254
15. Lee SY, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW. A case of intraductal papillary mucinous tumor of pancreas combined with early gastric cancer and MALToma of stomach. J Clin Gastroenterol 2002; 35: 109-110
16. Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999; 94: 470-473
17. Kobayashi G, Fujita N, Noda Y, Ito K, Horaguchi J, Takasawa O, Akaishi S, Tsuchiya T, Kobari M. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol 2005; 40: 744-751
18. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32
19. Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 2008; 143: 639-646; discussion 646
20. Choi MG, Kim SW, Han SS, Jang JY, Park YH. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg 2006; 141: 51-56; discussion 56
21. Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Katayose Y, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T. Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas. Pancreatology 2008; 8: 577-582
22. Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2002; 97: 2553-2558
23. Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005; 447: 794-799